Provectus boots its interim CEO following expense probe, 10 months after founder left under the same cloud
Ten months after Provectus Biopharmaceuticals $PVCT co- founder and CEO Craig Dees left the biotech and was then cited for finagling his expense account, interim CEO Peter Culpepper is getting the boot for the exact same reason.
The Knoxville, TN-based biotech said that Culpepper was fired after an investigation into “improper expense reimbursements.”
Provectus President Tim Scott will assume the CEO’s job while the company looks for a new chief.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.